Non-Hodgkin’s Lymphoma

• Most NHL are of B cell origin and express CD20

• Ranks 5th in cancer incidence and mortality

• Incidence: 54,900/year

• Prevalence: 300,000 cases

  • 65% low-grade or follicular
  • Transformation increases over time

• Median age at diagnosis: 60 years

• Median survival

  • Low-grade or follicular: 6.2 years
  • From transformation: 7 to 22 months

Previous slide

Next slide

Back to first slide

View graphic version